• 1
    Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995;92:23332342.
  • 2
    McDaniel MC, Eshtehardi P, Sawaya FJ, Douglas JS Jr, Samady H. Contemporary clinical applications of coronary intravascular ultrasound. JACC Cardiovasc Interv 2011;4:11551167.
  • 3
    Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW. Interobserver variability in coronary angiography. Circulation 1976;53:627632.
  • 4
    White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, Marcus ML. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984;310:819824.
  • 5
    Yong AS, Ng AC, Brieger D, Lowe HC, Ng MK, Kritharides L. Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve. Eur Heart J 2011;32:345353.
  • 6
    Christou MA, Siontis GC, Katritsis DG, Ioannidis JP. Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. Am J Cardiol 2007;99:450456.
  • 7
    Dattilo PB, Prasad A, Honeycutt E, Wang TY, Messenger JC. Contemporary patterns of fractional flow reserve and intravascular ultrasound use among patients undergoing percutaneous coronary intervention in the United States: Insights from the National Cardiovascular Data Registry. J Am Coll Cardiol 2012;60:23372339.
  • 8
    Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011;124:e574e651.
  • 9
    Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJJ, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:17031708.
  • 10
    Melikian N, De Bondt P, Tonino P, De Winter O, Wyffels Bartunek J, Heyndrickx GR, Fearon WF, Pijils NHJ, Wijns W, De Bruyne B. Fractional flow research and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. J Am Coll Cardiol Intv 2010;3:307314.
  • 11
    Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007;49:21052111.
  • 12
    Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213224.
  • 13
    Fearon WF, Bornschein B, Tonino PA, Gothe RM, Bruyne BD, Pijls NH, Siebert U. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation 2010;122:25452550.
  • 14
    De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012;367:9911001.
  • 15
    Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:15031516.
  • 16
    Nam CW, Mangiacapra F, Entjes R, Chung IS, Sels JW, Tonino PA, De Bruyne B, Pijls NH, Fearon WF; FAME Study Investigators. Functional SYNTAX Score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011;58:12111218.
  • 17
    Bech GJ, Droste H, Pijls NH, De Bruyne B, Bonnier JJ, Michels HR, Peels KH, Koolen JJ. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart 2001;86:547552.
  • 18
    Jimenez-Navarro M, Hernandez-Garcia JM, Alonso-Briales JH, Kuhlmorgen B, Gomez-Doblas JJ, Garcia-Pinilla JM, Lopez-Salguero R, Galvan Ede T. Should we treat patients with moderately severe stenosis of the left main coronary artery and negative FFR results? J Invasive Cardiol 2004;16:398400.
  • 19
    Legutko J, Dudek D, Rzeszutko L, Wizimirski M, Dubiel JS. Fractional flow reserve assessment to determine the indications for myocardial revascularisation in patients with borderline stenosis of the left main coronary artery. Kardiol Pol 2005;63:499506; discussion 507–508.
  • 20
    Suemaru S, Iwasaki K, Yamamoto K, Kusachi S, Hina K, et al. Coronary pressure measurement to determine treatment strategy for equivocal left main coronary artery lesions. Heart Vessels 2005;20:271277.
  • 21
    Lindstaedt M, Yazar A, Germing A, Fritz MK, Holland-Letz T, Mugge A, Bojara W. Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements. Am Heart J 2006;152:156 e1e9.
  • 22
    Courtis J, Rodes-Cabau J, Larose E, Potvin JM, Dery JP, et al. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses. Am J Cardiol 2009;103:943949.
  • 23
    Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, et al. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation 2009;120:15051512.
  • 24
    Kim HL, Koo BK, Nam CW, et al. Clinical and physiological outcomes of fractional flow reserve-guided percutaneous coronary intervention in patients with serial stenoses within one coronary artery. JACC Cardiovasc Interv 2012;5:10131018.
  • 25
    Pijls NH, Sels JW. Functional measurement of coronary stenosis. J Am Coll Cardiol 2012;59:10451057.
  • 26
    Koo BK, Park KW, Kang HJ, Cho YS, Chung WY, et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. Eur Heart J 2008;29:726732.
  • 27
    Koo BK, Kang HJ, Youn TJ, Chae IH, Choi DJ, et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol 2005;46:633637.
  • 28
    Ntalianis A, Sels JW, Davidavicius G, Tanaka N, Muller O, et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv 2010;3:12741481.
  • 29
    Park SJ, Ahn JM, Kang SJ. Paradigm shift to functional angioplasty: New insights for fractional flow reserve- and intravascular ultrasound-guided percutaneous coronary intervention. Circulation 2011;124:951957.
  • 30
    Klein LW, McPherson D. The diagnostic potential of intravascular ultrasound in the coronary arteries. Cardiovasc Rev Rep 1990;11:3136.
  • 31
    Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001;103:604616.
  • 32
    Kim JS, Hong MK, Ko YG, Choi D, Yoon JH, et al. Impact of intravascular ultrasound guidance on long-term clinical outcomes in patients treated with drug-eluting stent for bifurcation lesions: Data from a Korean multicenter bifurcation registry. Am Heart J 2011;161:180187.
  • 33
    Parise H, Maehara A, Stone GW, Leon MB, Mintz GS. Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era. Am J Cardiol 2011;107:374382.
  • 34
    Zhang Y, Farooq V, Garcia-Garcia HM, Bourantas CV, Tian N, Dong S, Li M, Yang S, Serruys PW, Chen SL. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: A meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. EuroIntervention 2012;8:855865.
  • 35
    Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 2008;29:18511857.
  • 36
    Park SJ, Kim YH, Park DW, Lee SW, Kim WJ, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv 2009;2:167177.
  • 37
    Kim SH, Kim YH, Kang SJ, Park DW, Lee SW, et al. Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. Am J Cardiol 2010;106:612618.
  • 38
    Jakabcin J, Spacek R, Bystron M, Kvasnak M, Jager J, Veselka J, Kala P, Cervinka P. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS. Catheter Cardiovasc Interv 2010;75:578583.
  • 39
    Claessen BE, Mehran R, Mintz GS, Weisz G, Leon MB, et al. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. JACC Cardiovasc Interv 2011;4:974981.
  • 40
    Hur SH, Kang SJ, Kim YH, Ahn JM, Park DW, Lee SW, Yun SC, Lee CW, Park SW, Park SJ. Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population. Catheter Cardiovasc Interv 2013;81:407416.
  • 41
    Ahmed K, Jeong MH, Chakraborty R, Ahn Y, Sim DS, et al. Role of intravascular ultrasound in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2011;108:814.
  • 42
    Park KW, Kang SH, Yang HM, Lee HY, Kang HJ, Cho YS, Youn TJ, Koo BK, Chae IH, Kim HS. Impact of intravascular ultrasound guidance in routine percutaneous coronary intervention for conventional lesions: data from the EXCELLENT trial. Int J Cardiol 2012;167:721726.
  • 43
    Chen SL YF, Zhang JJ, Kan J, Tian NL, Liu ZZ, Lin S, Lin L, Han YL, Santoso T, Zhou YJ, Jiang TM, Wen SY. Intravascular ultrasound-guided systematic two-stent techniques for coronary bifurcation lesions reduced late stent thrombosis and ST-elevation myocardial infarction. Circ Cardiovasc Interv, in press.
  • 44
    Witzenbichler B. Use of IVUS reduces stent thrombosis: Results from the prospective, multicenter ADAPT-DES study. J Am Coll Cardiol 2012;60:B6.
  • 45
    Puri R, Kapadia SR, Nicholls SJ, Harvey JE, Kataoka Y, Tuzcu EM. Optimizing outcomes during left main percutaneous coronary intervention with intravascular ultrasound and fractional flow reserve: The current state of evidence. JACC Cardiovasc Interv 2012;5:697707.
  • 46
    Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv 2009;2:10351046.
  • 47
    Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:16401645.
  • 48
    Diaz-Sandoval LJ, Bouma BE, Tearney GJ, Jang IK. Optical coherence tomography as a tool for percutaneous coronary interventions. Catheter Cardiovasc Interv 2005;65:492496.
  • 49
    Imola F, Mallus MT, Ramazzotti V, Manzoli A, Pappalardo A, Di Giorgio A, Albertucci M, Prati F. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. EuroIntervention 2010;6:575581.
  • 50
    Viceconte N, Chan PH, Barrero EA, Ghilencea L, Lindsay A, Foin N, Di Mario C. Frequency domain optical coherence tomography for guidance of coronary stenting. Int J Cardiol 2013;166:722728.
  • 51
    Stefano GT, Bezerra HG, Mehanna E, Yamamoto H, Fujino Y, Wang W, Attizzani G, Chamie D, Simon DI, Costa MA. Unrestricted utilization of frequency domain optical coherence tomography in coronary interventions. Int J Cardiovasc Imaging 2013;29:741752.
  • 52
    Prati F, Di Vito L, Biondi-Zoccai G, Occhipinti M, La Manna A, et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention 2012;8:823829.
  • 53
    Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111:15511555.
  • 54
    Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933939.
  • 55
    Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: A 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging 2012;5:433440.
  • 56
    Shiono Y, Kitabata H, Kubo T, Masuno T, Ohta S, et al. Optical coherence tomography-derived anatomical criteria for functionally significant coronary stenosis assessed by fractional flow reserve. Circ J 2012;76:22182225.
  • 57
    Gonzalo N, Escaned J, Alfonso F, Nolte C, Rodriguez V, et al. Morphometric assessment of coronary stenosis relevance with optical coherence tomography: A comparison with fractional flow reserve and intravascular ultrasound. J Am Coll Cardiol 2012;59:10801089.
  • 58
    Jasti V, Ivan E, Yalamanchili V, Wongpraparut N, Leesar MA. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation 2004;110:28312836.
  • 59
    Takayama T, Hodgson JM. Prediction of the physiologic severity of coronary lesions using 3D IVUS: Validation by direct coronary pressure measurements. Catheter Cardiovasc Interv 2001;53:4855.
  • 60
    Kang SJ, Lee JY, Ahn JM, Song HG, Kim WJ, et al. Intravascular ultrasound-derived predictors for fractional flow reserve in intermediate left main disease. JACC Cardiovasc Interv 2011;4:11681174.
  • 61
    Leesar MA, Masden R, Jasti V. Physiological and intravascular ultrasound assessment of an ambiguous left main coronary artery stenosis. Catheter Cardiovasc Interv 2004;62:349357.
  • 62
    de la Torre Hernandez JM, Hernandez Hernandez F, Alfonso F, Rumoroso JR, Lopez-Palop R, et al. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. J Am Coll Cardiol 2011;58:351358.
  • 63
    Abizaid A, Mintz GS, Pichard AD, Kent KM, Satler LF, Walsh CL, Popma JJ, Leon MB. Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and after percutaneous transluminal coronary angioplasty. Am J Cardiol 1998;82:423428.
  • 64
    Nishioka T, Amanullah AM, Luo H, Berglund H, Kim CJ, et al. Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: Comparison with stress myocardial perfusion imaging. J Am Coll Cardiol 1999;33:18701878.
  • 65
    Abizaid AS, Mintz GS, Mehran R, Abizaid A, Lansky AJ, et al. Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions. Circulation 1999;100:256261.
  • 66
    Stone G. VERDICT/FIRST: Prospective, Multicenter Study Examining the Correlation between IVUS and FFR Parameters in Intermediate Lesions. 2012, in press.
  • 67
    Waksman R, Legutko J, Singh J, Orlando Q, Marso S, et al. FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study. J Am Coll Cardiol 2013;61:917923.